Company intelligence / Profile preview
Antengene
Shanghai, Shanghai, Chinaantengene.com ↗
- Ownership
- Public · 6996
- Employees
- ~169
- Development stage
- Commercial
01
Overview
Lead product ATG‑010 (selinexor) has FDA approval for relapsed/refractory multiple myeloma and diffuse large B-cell lymphoma. Phase III trial in liposarcoma met its primary endpoint with significantly prolonged progression-free survival. Nine ongoing cross-regional clinical trials across Asia-Pacific; robust preclinical data presented at major conferences.
- Therapeutic areas
- HematologyOncology
- Modalities
- Small molecules (e.g., CD73 inhibitor)Monoclonal antibodies (mAbs)Bispecific antibodies (e.g., PD-L1/4-1BB)ADCs (antibody-drug conjugates)
- Industry
- Biotech
02
Drug pipeline
28 assets27 more assets in the full pipeline.
03
Partnerships
Global collaborations with undisclosed partners to advance biopharma innovation; specific partner names not listed but open to partnerships globally.
04
Financials
- Market cap
- $219.6M
- Total revenue
- $15.8M
- Enterprise value
- $143.6M
Beyond the preview
Go deeper on Antengene.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Antengene.